Tirzepatide 60mg Pen

    £134.00

    Tirzepatide 60mg Pen – GLP-1 and GIP Research Information

    Explore the scientific background of the Tirzepatide 60mg Pen and its association with dual GIP and GLP-1 receptor activity.

    Tirzepatide is a synthetic peptide investigated in clinical research involving glucose regulation, appetite signalling and metabolic health.

    Key information:

    • Dual GIP and GLP-1 receptor agonist
    • Relevant to metabolic and incretin research
    • Product presentation: labelled 60mg pen
    • Research topics: receptor signalling, glucose metabolism and pharmacology
    • Independent verification of product composition and quality is essential

    Important: The pictured 60mg pen has not been independently verified as an authorised UK medicinal product. This information is educational and does not establish suitability for human administration.